Clinical trial

Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I…

NCT00087438 · Radiation Therapy Oncology Group, Other · Completed

Key facts

NCT number NCT00087438
Title Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
Official title A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients With Medically Inoperable Stage I/II Non-Small Cell Lung Cancer
Lead sponsor Radiation Therapy Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Lung Cancer
Intervention type Radiation
Interventions stereotactic body radiation therapy
Enrollment 59
Start date May 1, 2004
Primary completion Mar 1, 2010
Completion Dec 1, 2016
First posted Jul 12, 2004
Last update posted Jan 16, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies